Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and Joan's Legacy
Carla Kim, PhD
Children's Hospital
Boston
MA
Dr. Kim’s hypothesis is that bronchioloalveolar carcinomas, a subtype of non-small cell lung cancer, are maintained by a small population of cells often referred to as cancer stem cells. Dr. Kim is identifying these stem cells and drugs that inhibit them.